The 5 Biggest Biotech Stocks – SPDR Gold Shares ETF … – Benzinga

ByChristian Tharp CMT biib, CELG, celgene, corporation, gen, nasdaq, regeneron, regn Comments Off

Biotech is big, and the industry has been big for quite some time.

As a matter of fact, biotechnology has been the second-best performing industry over the last two years.

Biotech stocks obviously come in all different shapes and sizes. Some investors like the small-caps, others prefer the middle of the road mid-caps.

However, at the end of the day, the big biotechs are the ones that make the headlines.

Below is a list of the five biggest biotech stocks by market capitalization.

The biotech stock with the fifth-largest market cap is Regeneron Pharmaceuticals Inc (NASDAQ: REGN).

At time of writing, Regeneron’s market cap sat just over $41 billion.

The fourth-largest biotech stock is Biogen Idec Inc (NASDAQ: BIIB).

Biogen’s market cap is more than double that of Regeneron at above $83 billion.

Coming in as the third-biggest biotech stock on the block is Celgene Corporation (NASDAQ: CELG).

Celgene has a market capitalization of $98 billion.

The second-largest biotech stock by market cap is Amgen, Inc. (NASDAQ: AMGN).

With a market cap of $120 billion, Amgen is still a distance from the largest biotech of them all.

The biggest biotech is Gilead Sciences, Inc. (NASDAQ: GILD).

Gilead is bigger than both Biogen and Regeneron put together with a market cap of over $155 billion.

All five stocks closed up in the green on Tuesday.

Excerpt from –